Search

Search Results
Results 4601 - 4610 of 4685 for multiple sclerosis
  • Aspartame Safety and Evidence
    Health - 7 Nov 2018
    All artificial sweeteners are firmly regulated and can only be used after they have been assessed rigorously for their safety.
  • What is Spinocerebellar Ataxia?
    Health - 16 Sep 2018
    Ataxia is a degenerative disease affecting the nervous system, presenting poor coordination and movement, difficulties with speech, walking, fine motor skills, swallowing, and vision. It mainly...
  • Physiotherapy Types
    Health - 23 Aug 2018
    Physiotherapy (PT) is a healthcare profession, which encompasses various treatment modalities such as massages, heat therapy, exercises, electrotherapy, patient education, and advice for treating an...
  • Diagnosis of Spasticity
    Health - 23 Aug 2018
    Spasticity is a clinical sign characterized by muscle over-activity and high tone spasms that is associated with several distinct neurological diseases. Timely diagnosis and management are essential...
  • Merck reports record results for 2015
    News - 10 Mar 2016
    Merck, a leading science and technology company, reported record results for 2015, emerging stronger from the transformation process that started in 2007. Net sales and EBITDA pre exceptionals were...
  • Elan first quarter total revenue increases 17% to $288.4 million
    News - 26 Apr 2012
    Elan Corporation, plc, today reported its first quarter 2012 financial results.
  • GTC Biotherapeutics reports total net loss of $1.7M for fourth-quarter 2009
    News - 12 Mar 2010
    GTC Biotherapeutics, Inc. today reported its financial results for the fourth quarter and fiscal year ended January 3, 2010. The total net loss for the fourth quarter was $1.7 million, or $0.09 per...
  • Gross sales of Acorda Therapeutics' ZANAFLEX CAPSULES and tablets increase 9.1% to $58.3M in 2009
    News - 23 Feb 2010
    Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2009.
  • Entyvio Pen
    Drug - 31 Jul 2025
    Consumer Medicine Information (CMI) about Entyvio Pen intended for persons living in Australia.
  • Entyvio IV
    Drug - 31 Jul 2025
    Consumer Medicine Information (CMI) about Entyvio IV intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback